California Academy of Family Physicians (CAFP)
MAY 14, 2025
Proposed Changes to Prescription Drug Coverage Prescription Drug Utilization Management- Implements utilization management and prior authorization for prescription drugs. Elimination of Acupuncture Optional Medi-Cal Benefit – Eliminates acupuncture as an optional benefit for all beneficiaries.
FDA Law Blog
SEPTEMBER 16, 2024
“Innovative manufacturing” is a somewhat ill-defined term, but the agency uses it to refer to any novel manufacturing that can increase product development speed, bolster supply chains, or prevent drug shortages. Supporting and utilizing ongoing initiatives for advanced manufacturing to address potential barriers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
MARCH 27, 2023
When a firm develops requirements for UDI, an important step is to determine if the products can utilize any of the existing general exceptions from the requirement per 21 CFR 801.30. Finally, as a general matter, every firm needs to make sure its supply chain stakeholders (e.g.,
FDA Law Blog
JUNE 3, 2021
Schlanger — While federal efforts to address prescription drug prices are debated, states have continued to pursue their own measures that require drug manufacturers and other entities in the drug supply chain to disclose information about pricing. See our previous coverage of such state laws here , here and here.)
FDA Law Blog
SEPTEMBER 13, 2021
Medicare negotiation authority; encourage biosimilars and generic drug utilization). The Plan also proposes establishing payment models to support the increased utilization of biosimilars and generics by further incentivizing providers to prescribe them. Increase Transparency and Strengthen Supply Chain and Research Capacity.
Expert insights. Personalized for you.
204 
Let's personalize your content